Science Explorer Back to mapMap
Discussion
Company · Seongnam-si · South Korea

Corestem (South Korea)

Research works
21
▲ 74% vs 2018-21
Citations
592
28.4 per fractional work
Top-10% rate
4.5%
all institutions 10.0%
Open access
73%
world 40%
International
14%
world 18%

Not ranked overall: Corestem (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Corestem (South Korea) work in?

In all years, 57% of research at Corestem (South Korea) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (19%), Neuroscience (10%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 12 fractional works · 56.5% of its workMedicine: 11 fractional works · 53.5% of its workGenetics: 4 fractional works · 19.1% of its workNeurology: 2 fractional works · 7.7% of its workRheumatology: 1 fractional works · 4.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.0% of its workPathology and Forensic Medicine: 1 fractional works · 3.5% of its workOncology: 1 fractional works · 2.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.8% of its workSurgery: 0 fractional works · 1.5% of its workRehabilitation: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.3% of its workDermatology: 0 fractional works · 1.2% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.2% of its workEmergency Medicine: 0 fractional works · 0.8% of its workOtorhinolaryngology: 0 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.3% of its workEmergency Medical Services: 0 fractional works · 0.8% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 1.0% of its workNutrition and Dietetics: 0 fractional works · 1.0% of its workVeterinary: 0 fractional works · 0.7% of its workSmall Animals: 0 fractional works · 0.7% of its workLife Sciences: 7 fractional works · 34.6% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 18.9% of its workMolecular Biology: 3 fractional works · 13.9% of its workCancer Research: 1 fractional works · 3.8% of its workBiochemistry: 0 fractional works · 0.8% of its workBiophysics: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 10.0% of its workCellular and Molecular Neuroscience: 1 fractional works · 4.4% of its workDevelopmental Neuroscience: 1 fractional works · 4.0% of its workNeurology: 0 fractional works · 1.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.4% of its workPharmacology: 0 fractional works · 2.4% of its workImmunology and Microbiology: 0 fractional works · 2.3% of its workImmunology: 0 fractional works · 2.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.7% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 7.5% of its workEngineering: 1 fractional works · 4.5% of its workBiomedical Engineering: 1 fractional works · 3.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.8% of its workMedia Technology: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 1.6% of its workMaterials Chemistry: 0 fractional works · 1.1% of its workBiomaterials: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 1.1% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.1% of its workChemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workALL ITS WORKCorestem (SouthKorea)21fractional works, all years
Life Sciences35%Physical Sciences7%Health Sciences57%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1153.5%
    2. Health Professions01.3%
    3. Nursing01.0%
    4. Veterinary00.7%
    1. Biochemistry, Genetics and Molecular Biology418.9%
    2. Neuroscience210.0%
    3. Pharmacology, Toxicology and Pharmaceutics02.4%
    4. Immunology and Microbiology02.3%
    5. Agricultural and Biological Sciences00.9%
    1. Engineering14.5%
    2. Materials Science01.6%
    3. Computer Science01.1%
    4. Chemistry00.3%
    1. Economics, Econometrics and Finance01.1%
    2. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.62× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.89× its world share, 0 worksImmunology and Micro…Neuroscience: 2.87× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 16.52× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.33× its world share, 0 worksComputer ScienceEngineering: 0.56× its world share, 1 worksEngineeringMaterials Science: 0.74× its world share, 0 worksMaterials ScienceHealth Professions: 0.49× its world share, 0 worksHealth ProfessionsMedicine: 2.66× its world share, 4 worksMedicineNursing: 4.95× its world share, 0 worksNursingVeterinary: 12.85× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.36× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 16.5×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics16.52×0 works
  2. Veterinary12.85×0 works
  3. Nursing4.95×0 works
  4. Immunology and Microbiology2.89×0 works
  5. Neuroscience2.87×0 works
  6. Medicine2.66×4 works
  7. Biochemistry, Genetics and Molecular Biology2.62×1 works
  8. Materials Science0.74×0 works
  9. Engineering0.56×1 works
  10. Health Professions0.49×0 works
  11. Economics, Econometrics and Finance0.36×0 works
  12. Computer Science0.33×0 works
  13. Agricultural and Biological Sciences0.20×0 works
  14. Social Sciences0.06×0 works

Who are the top researchers at Corestem (South Korea)?

Ranked on the quality score, Kyung Suk Kim and Tae Yong Lee lead among researchers whose main affiliation is Corestem (South Korea).

  1. 1 Kyung Suk Kim South Korea · #2,659,446 worldwide 2.1k citations · 61 works
  2. 2 Tae Yong Lee South Korea · #3,933,566 worldwide 250 citations · 16 works
All ranked researchers at Corestem (South Korea)

What are the most cited papers from Corestem (South Korea)?

The most cited paper from Corestem (South Korea) is "Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats" (Seong‐Ho Koh, Kyung Suk Kim, Mi‐Ran Choi et al., 2008), with 211 citations. Next come "Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis" (180) and "Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice" (143).

Most cited papers
#PaperReleasedCitations
1 Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats Seong‐Ho Koh, Kyung Suk Kim, Mi‐Ran Choi et al. · Brain Research Open access 3 Jul 2008 211
2 Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Ki‐Wook Oh, Chanil Moon, Seung Hyun Kim et al. · Stem Cells Translational Medicine Open access May 2015 180
3 Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice Heejaung Kim, Ho Kim, Mi‐Ran Choi et al. · Neuroscience Letters 30 Oct 2009 143
4 Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-β Secretion Min‐Young Noh, Su Min Lim, Ki‐Wook Oh et al. · Stem Cells Translational Medicine Open access 8 Jul 2016 110
5 Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis Mi‐Ran Choi, Seung Hyun Kim, Jiyoon Park et al. · Neuroscience Letters 2 Feb 2010 106
All 62 most cited papers, with filters and sorting

Which keywords describe research at Corestem (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Regeneration, Differentiation, Mesenchymal Stem Cells, Stromal Cells, Immunomodulation, Multipotent, Neurodegeneration and Inflammation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Regeneration4▲ 112×3 topics
  2. Differentiation4▲ 265×2 topics
  3. Mesenchymal Stem Cells4▲ 159×2 topics
  4. Stromal Cells4▲ 185×2 topics
  5. Immunomodulation3▲ 111×1 topic
  6. Multipotent3▲ 423×1 topic
  7. Inflammation2▲ 4.2×12 topics
  8. Neurodegeneration2▲ 30×3 topics
  9. Cancer2▲ 5.5×11 topics
  10. FUS/TLS2▲ 381×1 topic
  11. TDP-432▲ 381×1 topic
  12. Metabolism1▲ 10×8 topics
  13. Oxidative Stress1▲ 3.5×6 topics
  14. Apoptosis1▲ 15×6 topics
  15. Brain Development1▲ 29×2 topics
  16. Radiotherapy1▲ 13×2 topics

Which research topics does Corestem (South Korea) publish most on?

By volume in 2022-now: Effects of Radiation Exposure, Mesenchymal stem cell research, Plant-based Medicinal Research and Ginseng Biological Effects and Applications.

  1. 1 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Mesenchymal stem cell research Genetics 0 works
  3. 3 Plant-based Medicinal Research Pharmacology 0 works
  4. 4 Ginseng Biological Effects and Applications Molecular Biology 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
  7. 7 RNA Interference and Gene Delivery Molecular Biology 0 works
  8. 8 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  9. 9 Fatty Acid Research and Health Nutrition and Dietetics 0 works
  10. 10 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available72.7%not open27.3%

World: 40% of research is openly available.

with international co-authors14.5%domestic only85.5%

World: 18% is written across borders.

How has Corestem (South Korea)'s research output changed?

Output in 2022-2025 was 74% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Corestem (South Korea) as a percentage of every work published that year, 0.000067% in 2024.

still counting0.000025%0.000050%0.000075%Corestem (South Korea)0.000031% in 202520102020

Fractional works of Corestem (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Corestem (South Korea). Posts are plain text and can be reported.